SomnoMed Ltd (ASX: SOM) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

SomnoMed Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $29.26 million
P/E Ratio 136.99
Dividend Yield 0.00%
Shares Outstanding 140.32 million
Earnings per share -0.092
Dividend per share N/A
Year To Date Return -45.73%
Earnings Yield 0.73%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • SomnoMed Ltd (ASX: SOM)
    Latest News

    a woman
    ⏸️ Investing

    My 3 BEST small-cap stock ideas

    Escape meagre returns in the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) with shares of Bulletproof Group Ltd (ASX:BPF), Yowie Group Ltd (ASX:YOW)…

    Read more »

    a woman
    ⏸️ Investing

    5 ASX small-cap stocks to buy today

    Hansen Technologies Limited (ASX:HSN) and Somnomed Limited (ASX:SOM) offer compelling opportunities.

    Read more »

    a woman
    ⏸️ Investing

    The top 10 small cap stocks on my watchlist

    It's time to consider diversifying your portfolio away from the Top 20

    Read more »

    a woman
    ⏸️ Investing

    Is Somnomed Limited a better buy than ResMed Inc. (CHESS)?

    Somnomed Limited (ASX:SOM) makes a cheaper version of the devices of ResMed Inc. (CHESS) and Fisher & Paykel Healthcare Corp…

    Read more »

    a woman
    ⏸️ Investing

    7 small-cap ASX stocks you need to know about

    Many investors are ignoring the enormous upside potential possessed by some of Australia's smaller public companies.

    Read more »

    a woman
    ⏸️ Investing

    4 defensive stocks to get through the market crash

    It's a good idea to hold onto companies like Burson Group Ltd (ASX:BAP) and Veda Group Ltd (ASX:VED) through tough…

    Read more »

    a woman
    ⏸️ Investing

    Did you miss this news on the ASX this week?

    A run-down of this week’s major market announcements.

    Read more »

    a woman
    ⏸️ Investing

    Fisher & Paykel Healthcare Corp Ltd, ResMed Inc. (CHESS) or Somnomed Limited: Which should you buy?

    Fisher & Paykel Healthcare Corp Ltd (ASX:FPH), ResMed Inc. (CHESS) (ASX:RMD) and Somnomed Limited (ASX:SOM) all manufacture devices to treat…

    Read more »

    a woman
    ⏸️ Investing

    Why Somnomed Limited is surging higher today

    Somnomed Limited (ASX:SOM) has the potential to grow faster than either ResMed Inc. (CHESS) (ASX:RMD) or Fisher & Paykel Healthcare…

    Read more »

    a woman
    ⏸️ Investing

    Have you bought these 5 super small-cap stocks?

    I should have taken my own advice and bought Yowie Group Ltd (ASX:YOW), Senetas Corporation Limited (ASX:SEN), Bellamy's Australia Ltd…

    Read more »

    a woman
    ⏸️ Investing

    The ultimate set-and-forget portfolio: 10 ASX stocks to buy today

    Woolworths Limited (ASX:WOW), Coca-Cola Amatil Ltd (ASX:CCL), Flight Centre Travel Group Ltd (ASX:FLT) and XERO FPO NZ (ASX:XRO) are all…

    Read more »

    a woman
    ⏸️ Investing

    Here's why Somnomed Limited shares are soaring higher today

    Somnomed Limited (ASX:SOM) still appears to be an attractive investment proposition at $2.84 per share.

    Read more »

    SOM ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About SomnoMed Ltd

    SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, SomTabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the onlyreportable segment. Substantial revenue is realized from the European region.

    SOM Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    17 Apr 2024 $0.22 $0.01 4.76% 335,303 $0.22 $0.23 $0.22
    16 Apr 2024 $0.21 $-0.01 -4.65% 262,429 $0.24 $0.26 $0.21
    15 Apr 2024 $0.22 $-0.01 -4.44% 517,468 $0.22 $0.22 $0.21
    12 Apr 2024 $0.23 $0.02 9.52% 148,806 $0.22 $0.23 $0.21
    11 Apr 2024 $0.21 $0.01 4.88% 2,741,482 $0.21 $0.22 $0.21
    10 Apr 2024 $0.21 $-0.09 -30.21% 1,095,710 $0.28 $0.28 $0.20
    26 Mar 2024 $0.30 $0.02 7.28% 18,443 $0.28 $0.30 $0.28
    25 Mar 2024 $0.27 $0.00 0.00% 116,799 $0.28 $0.28 $0.26
    22 Mar 2024 $0.27 $-0.02 -6.80% 92,197 $0.29 $0.29 $0.27
    21 Mar 2024 $0.29 $0.02 7.18% 9,700 $0.28 $0.29 $0.28
    20 Mar 2024 $0.28 $-0.02 -6.71% 138,050 $0.29 $0.29 $0.27
    19 Mar 2024 $0.30 $0.00 0.00% 74,956 $0.30 $0.30 $0.30

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    22 Feb 2024 Neil Verdal-Austin Transfer 160,000 $64,000
    Off-market transfer. Assuming off market transfer of shares
    22 Feb 2024 Neil Verdal-Austin Transfer 160,000 $64,000
    Off-market transfer. Assuming off market transfer of shares
    28 Sep 2023 Neil Verdal-Austin Issued 41,650 $24,990
    Rights issue.
    28 Sep 2023 Amrita Blickstead Issued 23,856 $14,313
    Rights issue.
    28 Sep 2023 Michael Gordon Issued 63,090 $37,854
    Rights issue.
    28 Sep 2023 Gaetano (Guy) Russo Issued 90,839 $54,503
    Rights issue.
    25 Sep 2023 Hilton Brett Issued 39,854 $23,912
    Rights issue.
    25 Sep 2023 Hamish Corlett Issued 4,420,605 $2,652,363
    Rights issue.
    08 Sep 2023 Hamish Corlett Issued 5,840,618 $3,504,370
    Rights issue.
    08 Sep 2023 Hilton Brett Issued 59,349 $35,609
    Rights issue.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Michael Gordon Non-Executive Director Aug 2020
    Mr Gordon is a Director of K Sleep Holdings Pty Limited Koala, a direct to consumer household goods retailer. Michael was previously the CFO of Different Technologies, a property technology company, and before that Michael was CFO of Rokt, a marketing technology company with more than US$300m in revenue. Prior to Rokt, Michael was the Group CFO and MD of Group Services for Greenlit Brands Pty Limited. Greenlit Brands grew from a turnover of A$250m (Freedom) to a A$2.4 billion vertically integrated retailer based in Australia and New Zealand and included the brands, Freedom, Snooze, Fantastic, Plush, OMF, Best & Less and Harris Scarfe. Prior to Greenlit Brands, Michael spent ten years with PricewaterhouseCoopers in South Africa, the United Kingdom and Australia specialising in the retail and pharmaceutical industries with experience in audit, taxation M&A and IPOs.
    Mr Gaetano (Guy) Alfred Gerrard Russo Non-Executive ChairmanNon-Executive Director Aug 2020
    Mr Russo is an accomplished business leader with a commercial and customer focussed background working in Australia and internationally. In addition to Chairman of SomnoMed he is Chairman of Guzman y Gomez Mexican Kitchen (GYG), Australia's growing restaurant business. Previously, Guy has served as CEO, Wesfarmers Department Store Division (Kmart & Target); Managing Director, Kmart Australia & NZ; President, McDonald's Greater China; CEO McDonald's Australia Ltd and Chairman of onald McDonald House Children's Charities. Guy is perhaps well known in Australia for his leadership in turning Kmart into the largest and profitable retail department store in the country. He has been a member of YPO since 2006, served as a member of the Business Council of Australia, and won industry awards for leadership in diversity in employment.
    Mr Hamish James Corlett Non-Executive Director May 2018
    Mr Corlett is a founder and director of TDM Growth Partners, a leading private investment firm in long term investments in companies globally. TDM made its first investment in SomnoMed in April 2010 and has been a substantial shareholder in the Company since October 2012. Prior to TDM, Hamish worked as an Investment Manager at Caledonia Investments, a global fund manager. Hamish also worked in London in an operating role for an ecommerce start up and in Sydney at Caliburn Partnership (now Greenhill) in corporate advisory. Hamish is also a Non-Executive Director QBiotics Group Limited.
    Ms Amrita Blickstead Executive DirectorJoint CEO Feb 2024
    Ms Blickstead is the former Chief Operating and Marketing Officer at eBay Australia. The foundation of her career began in medical devices as a Biomedical Engineer at Cochlear and Ventracor .
    Ms Karen Borg Executive DirectorJoint CEO Feb 2024
    Ms Borg has a career in the medical devices sector. She has led businesses within Johnson & Johnson Medical and ResMed, as well as health and industry organizations for state and federal government. Most recently, she was the CEO of Catholic Healthcare.
    Mr Terence Anthony Flitcroft Company Secretary
    -
    Darren Collins Chief Financial Officer
    -
    Terence Anthony Flitcroft Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 40,281,683 40.66%
    National Nominees Limited 14,541,201 14.68%
    Equity Plan Services Pty Ltd 4,617,834 4.66%
    Citicorp Nominees Pty Limited 4,079,645 4.12%
    Dottie Investments Pty Ltd 3,650,487 3.68%
    Howarth PAF Pty Ltd <The Howarth Foundation A/C> 2,156,722 2.18%
    Belgove Pty Ltd 2,053,265 2.07%
    Ginga Pty Ltd 1,739,045 1.75%
    BNP Paribas Nominees Pty Ltd <ACF Clearstream A/C> 1,703,127 1.72%
    Bond Street Custodians Ltd <Salter – D79836 A/C> 1,600,000 1.61%
    J P Morgan Nominees Australian Pty Limited 1,217,842 1.23%
    P Neustadt Holdings Pty Ltd <Belgove Super Fund A/C> 1,082,171 1.09%
    Timbina Pty Ltd <Timbina Super Fund A/C> 1,073,764 1.08%
    REM Medical Pty Ltd <Cocoon Super Fund A/C> 876,135 0.88%
    Golden Words Pty Ltd 775,399 0.78%
    Honne Investments Pty Limited 600,000 0.61%
    Thirty Sixth Vilmar Pty Ltd 591,993 0.60%
    The Mulloon Institute Ltd 533,048 0.54%
    Howarth PAF Pty Ltd <Howarth Charitable Fund A/C> 523,771 0.53%
    Mr Edward Palmisano 484,631 0.49%

    Profile

    since

    Note